CORNERSTONE(TM) 3.0 Automation Solution to Support
Purdue Pharma Sales Representatives
ATLANTA, Sept. 14 /PRNewswire/ -- IMS HEALTH Strategic Technologies today
announced that Purdue Pharma L.P., a leading provider of pain-relief
pharmaceutical products, has chosen the CORNERSTONE(TM) 3.0 automation
solution for efficient delivery of market research and sales management
information to the pharmaceutical company's U.S.-based sales representatives.
The CORNERSTONE 3.0 system will enable Purdue Pharma sales representatives
to quickly share and integrate sales and marketing information. Purdue Pharma
selected the CORNERSTONE 3.0 system because of its flexible technology that
meets end-user requirements, as well as the ability of IMS HEALTH Strategic
Technologies to integrate all functions, including hardware services,
training, help-desk support and facilities management.
"IMS HEALTH Strategic Technologies has a unique vision of
technology-enabled selling, and are able to deliver on the promise of
providing the systems, processes and experience to implement a sales and
marketing solution," said Ron Levine, Vice President of Purdue Pharma. "Our
decision to partner with IMS HEALTH Strategic Technologies is based on their
established track record and strong customer base that testifies to a 'whole
product' approach."
"We are excited to establish a partnership with Purdue Pharma," said Doug
Brainard, Vice President, Business Development of IMS HEALTH Strategic
Technologies. "The CORNERSTONE 3.0 system will be the foundation that
supports Purdue Pharma's ability to understand their customers better and
manage client relationships more productively."
IMS HEALTH Strategic Technologies is the global leader in pharmaceutical
sales and marketing automation systems, with a customer base of more than
35,000 users worldwide. The company offers sales and marketing applications
which can be integrated with all client-critical databases to provide customer
and business insights.
IMS HEALTH Strategic Technologies is a unit of IMS HEALTH (NYSE: RX), the
world's leading provider of information solutions to the pharmaceutical and
healthcare industries. With more than $1 billion in 1997 revenue, IMS HEALTH
operates in over 90 countries. IMS HEALTH is the largest pharmaceutical
manufacturer information partner, with over 40 years' experience in the
industry. Key products and services integral to customer day-to-day
operations include: market research for prescription and over-the-counter
pharmaceutical products; sales management information to optimize sales force
productivity; technology enabled selling solutions for sales and marketing
decision-making; and technology systems and information services that support
managed care organizations. Additional information is available at
http://www.imshealth.com.
Purdue Pharma L.P. and its associated company, The Purdue Frederick
Company, develop and market a variety of proprietary patented products,
including MS Contin(R) (morphine sulfate controlled-release) tablets and
OxyContin(R) (oxycodone hydrochloride controlled-release) tablets. Other
major products include Betadine(R) antiseptics, the leading antiseptic brand
worldwide, and Uniphyl(R) (theophylline anhydrous controlled-release) tablets.
Purdue Pharma is noted for its proprietary controlled-release technology in
various dosage forms and routes of administration.
SOURCE IMS HEALTH Strategic Technologies
 back to top
Related links:
http://www.imshealth.com
Company News On-Call: http://www.prnewswire.com or
fax, 800-758-5804, ext. 115785
CONTACT:
Ken Goodgames of IMS HEALTH, 404-841-4898
|
